litlas
ログインアカウント作成

Mark A. Dawson

1999–2025 年に発表

78
論文数
17,907
被引用数
52
h 指数
75
i10 指数

被引用数

Mark A. Dawson の年別被引用数1948 年: 被引用 1 件1969 年: 被引用 1 件1993 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 3 件2004 年: 被引用 2 件2008 年: 被引用 5 件2009 年: 被引用 11 件2010 年: 被引用 46 件2011 年: 被引用 54 件2012 年: 被引用 105 件2013 年: 被引用 176 件2014 年: 被引用 222 件2015 年: 被引用 217 件2016 年: 被引用 182 件2017 年: 被引用 210 件2018 年: 被引用 215 件2019 年: 被引用 769 件2020 年: 被引用 883 件2021 年: 被引用 1,041 件2022 年: 被引用 879 件2023 年: 被引用 695 件2024 年: 被引用 1,170 件2025 年: 被引用 649 件2026 年: 被引用 22 件1949〜1968 年は被引用が無いため表示していません1970〜1992 年は被引用が無いため表示していません1994〜1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません2005〜2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,775 件、この内訳の 26.9%中国: 引用元論文 2,082 件、この内訳の 20.2%イギリス: 引用元論文 707 件、この内訳の 6.9%ドイツ: 引用元論文 577 件、この内訳の 5.6%オーストラリア: 引用元論文 410 件、この内訳の 4%フランス: 引用元論文 355 件、この内訳の 3.4%イタリア: 引用元論文 354 件、この内訳の 3.4%カナダ: 引用元論文 260 件、この内訳の 2.5%日本: 引用元論文 230 件、この内訳の 2.2%スペイン: 引用元論文 222 件、この内訳の 2.2%オランダ: 引用元論文 168 件、この内訳の 1.6%インド: 引用元論文 154 件、この内訳の 1.5%
0%26.9%その他 19.6%

機関

分野

  • Biochemistry, Genetics and Molecular Biology57.5%
  • Medicine31.2%
  • Immunology and Microbiology5.6%
  • Agricultural and Biological Sciences1.2%
  • Chemistry1.1%
  • Engineering0.8%
  • その他2.6%

トピック

  • Epigenetics and DNA Methylation7.6%
  • Protein Degradation and Inhibitors6.7%
  • Histone Deacetylase Inhibitors Research4.4%
  • RNA modifications and cancer4%
  • Ubiquitin and proteasome pathways3%
  • Cancer-related gene regulation2.9%
  • その他71.4%

共著者

全論文

検索で開く
  1. Cancer Epigenetics: From Mechanism to Therapy

    著者: Mark A. Dawson, Tony Kouzarides - Cell 2012 被引用: 3,240

  2. Targeting the epigenetic regulation of antitumour immunity

    著者: Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, Ricky W. Johnstone - Nature Reviews Drug Discovery 2020 被引用: 620

  3. Non-genetic mechanisms of therapeutic resistance in cancer

    著者: Jean‐Christophe Marine, Sarah‐Jane Dawson, Mark A. Dawson - Nature reviews. Cancer 2020 被引用: 615

  4. An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

    著者: Marian L. Burr, Christina E. Sparbier, Kah Lok Chan, Yih-Chih Chan, Ariena Kersbergen, Enid Y.N. Lam, Elizabeth Azidis-Yates, Dane Vassiliadis, Charles C. Bell, Omer Gilan, Susan Jackson, Lavinia Tan, Stephen Q. Wong, Sebastian Hollizeck, Ewa M. Michalak, Hannah V. Siddle, Michael T. McCabe, Rab K. Prinjha, Glen Guerra, Benjamin Solomon, Shahneen Sandhu, Sarah‐Jane Dawson, Paul A. Beavis, Richard W. Tothill, Carleen Cullinane, Paul J. Lehner, Kate D. Sutherland, Mark A. Dawson - Cancer Cell 2019 被引用: 642

  5. A druggable copper-signalling pathway that drives inflammation

    著者: Stéphanie Solier, Sebastian Müller, Tatiana Cañeque, Antoine Versini, Arnaud Mansart, Fabien Sindikubwabo, Leeroy Baron, Laila Emam, Pierre Gestraud, G. Dan Pantoş, Vincent Gandon, Christine Gaillet, Ting‐Di Wu, Florent Dingli, Damarys Loew, Sylvain Baulande, Sylvère Durand, Valentin Sencio, Cyril Robil, François Trottein, David Péricat, Emmanuelle Näser, Céline Cougoule, Étienne Meunier, Anne-Laure Bègue, Hélène Salmon, Nicolas Manel, Alain Puisieux, Sarah Watson, Mark A. Dawson, Nicolas Servant, Guido Kroemer, Djillali Annane, Raphaël Rodriguez - Nature 2023 被引用: 311

  6. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

    著者: Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan, James C. Williamson, Katherine Woods, Paul A. Beavis, Enid Y.N. Lam, Melissa A. Henderson, Charles C. Bell, Sabine Stolzenburg, Omer Gilan, Stuart Bloor, Tahereh Noori, David W. Morgens, Michael C. Bassik, Paul J. Neeson, Andreas Behren, Phillip K. Darcy, Sarah‐Jane Dawson, Ilia Voskoboinik, Joseph A. Trapani, Jonathan Cebon, Paul J. Lehner, Mark A. Dawson - Nature 2017 被引用: 969

  7. The roles of DNA, RNA and histone methylation in ageing and cancer

    著者: Ewa M. Michalak, Marian L. Burr, Andrew J. Bannister, Mark A. Dawson - Nature Reviews Molecular Cell Biology 2019 被引用: 585

  8. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    著者: Mark A. Dawson, Rab K. Prinjha, Antje Dittmann, George Giotopoulos, Marcus Bantscheff, Wai-In Chan, Samuel C. Robson, Chun‐wa Chung, Carsten Hopf, Mikhail M. Savitski, Carola Huthmacher, Emma Gudgin, Dave Lugo, Sören Beinke, Trevor Chapman, Emma J. Roberts, Peter E. Soden, Kurt R. Auger, Olivier Mirguet, Konstanze Doehner, Ruud Delwel, Alan K. Burnett, Philip D. Jeffrey, Gerard Drewes, Kevin Lee, Brian J.P. Huntly, Tony Kouzarides - Nature 2011 被引用: 1,532

  9. Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

    著者: Omer Gilan, Inmaculada Rioja, Kathy Knezevic, Matthew Bell, Miriam M. Yeung, Nicola Harker, Enid Y.N. Lam, Chun‐wa Chung, Paul Bamborough, M. Petretich, Marjeta Urh, Stephen J. Atkinson, Anna K. Bassil, Emma J. Roberts, Dane Vassiliadis, Marian L. Burr, Alex Preston, Christopher R. Wellaway, Thilo Werner, James R. Gray, Anne‐Marie Michon, Thomas Gobbetti, Vinod Kumar, Peter E. Soden, Andrea Haynes, Johanna Vappiani, David F. Tough, S. Taylor, Sarah‐Jane Dawson, Marcus Bantscheff, Matthew Lindon, Gerard Drewes, Emmanuel H. Demont, Danette L. Daniels, Paola Grandi, Rab K. Prinjha, Mark A. Dawson - Science 2020 被引用: 428

  10. Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity

    著者: Andrew A. Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic, Wesley Blackaby, David Hardick, Yih-Chih Chan, Ali Motazedian, Andrea Gillespie, Dane Vassiliadis, Enid Y.N. Lam, Kevin Tran, Byron Andrews, Michael E. Harbour, Lina Vasiliauskaitė, Claire J. Saunders, Georgia Tsagkogeorga, Aleksandra Azevedo, Joanna Obacz, Ewa S. Pilka, Marie Carkill, Laura MacPherson, Elanor N. Wainwright, Brian Liddicoat, Benjamin J. Blyth, Mark R. Albertella, Oliver Rausch, Mark A. Dawson - Cancer Discovery 2023 被引用: 115

  11. Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA

    著者: Lavinia Tan, Shahneen Sandhu, Rebecca Lee, James Li, Jason Callahan, Sarah Ftouni, Nathalie Dhomen, Philippa Middlehurst, Andrea Wallace, Jeanette Raleigh, Athena Hatzimihalis, Michael A. Henderson, Mark Shackleton, Andrew Haydon, Victoria Mar, David Gyorki, D. Oudit, Mark A. Dawson, Rodney J. Hicks, Paul Lorigan, Grant A. McArthur, Richard Marais, Stephen Q. Wong, Sarah‐Jane Dawson - Annals of Oncology 2019 被引用: 190

  12. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells

    著者: Iva A. Tchasovnikarova, Richard T. Timms, Nicholas J. Matheson, Kim Wals, Robin Antrobus, Berthold Göttgens, Gordon Dougan, Mark A. Dawson, Paul J. Lehner - Science 2015 被引用: 372

  13. Non-genetic determinants of malignant clonal fitness at single-cell resolution

    著者: Katie Fennell, Dane Vassiliadis, Enid Y.N. Lam, Luciano G. Martelotto, Jesse J. Balic, Sebastian Hollizeck, Tom Weber, Timothy Semple, Qing Wang, Denise C. Miles, Laura MacPherson, Yih-Chih Chan, Andrew A. Guirguis, Lev M. Kats, Emily Wong, Sarah‐Jane Dawson, Shalin H. Naik, Mark A. Dawson - Nature 2021 被引用: 160

  14. HBO1 is required for the maintenance of leukaemia stem cells

    著者: Laura MacPherson, Juliana Anokye, Miriam M. Yeung, Enid Y.N. Lam, Yih-Chih Chan, Chen-Fang Weng, Paul Yeh, Kathy Knezevic, Miriam Butler, Annabelle Hoegl, Kah Lok Chan, Marian L. Burr, Linden J. Gearing, Tracy A. Willson, Joy Liu, Jarny Choi, Yuqing Yang, Rebecca A. Bilardi, Hendrik Falk, Nghi Nguyen, Paul A. Stupple, Thomas S. Peat, Ming Zhang, Melanie de Silva, Catalina Carrasco‐Pozo, Vicky M. Avery, Poh Sim Khoo, Olan Dolezal, Matthew L. Dennis, Stewart D. Nuttall, Regina Surjadi, Janet Newman, Bin Ren, David J. Leaver, Yuxin Sun, Jonathan B. Baell, Oliver M. Dovey, George S. Vassiliou, Florian Grebien, Sarah‐Jane Dawson, Ian P. Street, Brendon J. Monahan, Christopher J. Burns, Chunaram Choudhary, Marnie E. Blewitt, Anne K. Voss, Tim Thomas, Mark A. Dawson - Nature 2019 被引用: 174

  15. BET inhibitor resistance emerges from leukaemia stem cells

    著者: Chun Yew Fong, Omer Gilan, Enid Y.N. Lam, Alan F. Rubin, Sarah Ftouni, Dean Tyler, Kym L. Stanley, Devbarna Sinha, Paul Yeh, Jessica Morison, George Giotopoulos, Dave Lugo, Philip Jeffrey, Stanley Chun-Wei Lee, Christopher Carpenter, Richard Gregory, Robert G. Ramsay, Steven Lane, Omar Abdel‐Wahab, Tony Kouzarides, Ricky W. Johnstone, Sarah‐Jane Dawson, Brian J.P. Huntly, Rab K. Prinjha, Anthony T. Papenfuss, Mark A. Dawson - Nature 2015 被引用: 548

  16. The Epigenetic Hallmarks of Cancer

    著者: Manel Esteller, Mark A. Dawson, Cigall Kadoch, Feyruz V. Rassool, Peter A. Jones, Stephen B. Baylin - Cancer Discovery 2024 被引用: 133

  17. The cancer epigenome: Concepts, challenges, and therapeutic opportunities

    著者: Mark A. Dawson - Science 2017 被引用: 380

  18. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer

    著者: Shikhar Sharma, Chi‐Yeh Chung, Sean Uryu, Jelena Petrovic, Joan Cao, Amanda J. Rickard, Nataliya Nady, S.E. Greasley, Eric F. Johnson, Oleg Brodsky, Showkhin Khan, Hui Wang, Zhenxiong Wang, Yong Zhang, Konstantinos Tsaparikos, Lei Chen, Anthony Mazurek, John D. Lapek, Pei‐Pei Kung, Scott C. Sutton, Paul Richardson, Eric C. Greenwald, Shinji Yamazaki, Rhys Jones, Karen A. Maegley, Patrick Bingham, Hieu Lam, Alexandra E. Stupple, Aileen Kamal, Anderly C. Chüeh, Anthony N. Cuzzupe, Benjamin J. Morrow, Bin Ren, Catalina Carrasco‐Pozo, Chin Wee Tan, Dharmesh D. Bhuva, Elizabeth Allan, Elliot Surgenor, François Vaillant, Havva Pehlivanoglu, Hendrik Falk, James R. Whittle, Janet Newman, Joseph Cursons, Judy P. Doherty, Karen L. White, Laura MacPherson, Mark Devlin, Matthew L. Dennis, Meghan Hattarki, Melanie de Silva, Michelle A. Camerino, Miriam Butler, Olan Dolezal, Patricia A. Pilling, Richard C. Foitzik, Paul A. Stupple, H. Rachel Lagiakos, Scott R. Walker, Soroor Hediyeh-zadeh, Stewart D. Nuttall, Sukhdeep K. Spall, Susan A. Charman, Theresa Connor, Thomas S. Peat, Vicky M. Avery, Ylva E. Bozikis, Yuqing Yang, Ming Zhang, Brendon J. Monahan, Anne K. Voss, Tim Thomas, Ian P. Street, Sarah‐Jane Dawson, Mark A. Dawson, Geoffrey J. Lindeman, Melissa J. Davis, Jane E. Visvader, Thomas A. Paul - Cell chemical biology 2023 被引用: 69

  19. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS

    著者: Rachel Deplus, Benjamin Delatte, Marie K. Schwinn, Matthieu Defrance, Jacqui Méndez, Nancy E. Murphy, Mark A. Dawson, Michael Volkmar, Pascale Putmans, Emilie Calonne, Alan H. Shih, Ross L. Levine, Olivier Bernard, Thomas Mercher, Éric Solary, Marjeta Urh, Danette L. Daniels, François Fuks - The EMBO Journal 2013 被引用: 489

  20. Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

    著者: Rishu Agarwal, Yih-Chih Chan, Constantine S. Tam, Tane Hunter, Dane Vassiliadis, Charis E. Teh, Rachel Thijssen, Paul Yeh, Stephen Q. Wong, Sarah Ftouni, Enid Y.N. Lam, Mary Ann Anderson, Christiane Pott, Omer Gilan, Charles C. Bell, Kathy Knezevic, Piers Blombery, Kathleen C. Rayeroux, Adrian Zordan, Jason Li, David C.S. Huang, Meaghan Wall, John F. Seymour, Daniel H.D. Gray, Andrew W. Roberts, Mark A. Dawson, Sarah‐Jane Dawson - Nature Medicine 2018 被引用: 204

  21. Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia

    著者: Özgen Deniz, Mamataz Ahmed, Christopher D Todd, Ana Rio‐Machín, Mark A. Dawson, Miguel R. Branco - Nature Communications 2020 被引用: 149

  22. Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

    著者: Charles C. Bell, Katie Fennell, Yih-Chih Chan, Florian Rambow, Miriam M. Yeung, Dane Vassiliadis, Luis E. Lara Gonzalez, Paul Yeh, Luciano G. Martelotto, Aljosja Rogiers, Brandon E. Kremer, Olena Barbash, Helai P. Mohammad, Timothy M. Johanson, Marian L. Burr, Arindam Dhar, Natalie O. Karpinich, Luyi Tian, Dean Tyler, Laura MacPherson, Junwei Shi, Nathan Pinnawala, Chun Yew Fong, Anthony T. Papenfuss, Sean M. Grimmond, Sarah‐Jane Dawson, Rhys S. Allan, Ryan G. Kruger, Christopher R. Vakoc, David L. Goode, Shalin H. Naik, Omer Gilan, Enid Y.N. Lam, Jean‐Christophe Marine, Rab K. Prinjha, Mark A. Dawson - Nature Communications 2019 被引用: 180

  23. CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity

    著者: April C. Watt, Paloma Cejas, Molly J. DeCristo, Otto Metzger, Enid Y.N. Lam, Xintao Qiu, Haley BrinJones, Nikolas Kesten, Rhiannon Coulson, Alba Font‐Tello, Klothilda Lim, Raga Vadhi, Veerle W. Daniëls, Joan Montero, Len Taing, Clifford A. Meyer, Omer Gilan, Charles C. Bell, Keegan Korthauer, Claudia Giambartolomei, Bogdan Paşaniuc, Ji-Heui Seo, Matthew L. Freedman, X. Cynthia, Matthew J. Ellis, Ian E. Krop, Eric P. Winer, Anthony Letai, Myles Brown, Mark A. Dawson, Henry W. Long, Jean J. Zhao, Shom Goel - Nature Cancer 2020 被引用: 110

  24. Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes

    著者: Christina E. Sparbier, Andrea Gillespie, Juliana Gomez, Nishi Kumari, Ali Motazedian, Kah Lok Chan, Charles C. Bell, Omer Gilan, Yih-Chih Chan, Sarah Popp, Daniel J. Gough, Mélanie Eckersley-Maslin, Sarah‐Jane Dawson, Paul J. Lehner, Kate D. Sutherland, Patricia Ernst, Gerard M. McGeehan, Enid Y.N. Lam, Marian L. Burr, Mark A. Dawson - Nature Cell Biology 2023 被引用: 36